Comparing the efficacy of allopurinol, febuxostat, and benzbromarone in a regional hospital: a retrospective cohort study

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: TSENG, Hsiang-Yi (Tungs’ Taichung MetroHarbor Hospital, Department of Pharmacy, Taichung, China Taiwan)
  • Co-author(s): Rung-Wei Zhang: Department of Pharmacy, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China;, Taichung City New Pharmacist Association, Taichung, Taiwan, Province of China
    Hsiang-Yi Tseng: Department of Pharmacy, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China;, Taichung City New Pharmacist Association, Taichung, Taiwan, Province of China
  • Abstract:

    Background

    Allopurinol, febuxostat, and benzbromarone were the most common oral urate lowering medications. To find out the most efficient treatment of gout is a great challenge for us.

    Purpose

    To compare the efficacy of the urate lowering agents: febuxostat, allopurinol, and benzbromarone.

    Methods

    We performed a preliminary, retrospective..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login